---
title: "Spectral AI | 8-K: FY2026 Q2 Revenue: USD 3.524 M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295735671.md"
datetime: "2026-08-13T02:47:29.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295735671.md)
  - [en](https://longbridge.com/en/news/295735671.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295735671.md)
generator: "portal-rs"
---

# Spectral AI | 8-K: FY2026 Q2 Revenue: USD 3.524 M

Revenue: As of FY2026 Q2, the actual value is USD 3.524 M.

EPS: As of FY2026 Q2, the actual value is USD -0.13.

EBIT: As of FY2026 Q2, the actual value is USD -3.628 M.

The provided reference, a Form 8-K filing by Spectral AI, Inc., announces the company’s financial results for the quarter ended June 30, 2026, issued on August 11, 2026, along with a press release (Exhibit 99.1) containing these results. However, the actual detailed financial and operational metrics, including revenue, net income, gross margin, operating profit, operating costs, cash flow, or any company-specific indicators, are not included within the text of this Form 8-K. Additionally, the reference does not contain any forward-looking statements, outlook, or guidance regarding future financial performance or operational plans for Spectral AI, Inc.

### Related Stocks

- [MDAI.US](https://longbridge.com/en/quote/MDAI.US.md)

## Related News & Research

- [Spectral AI (MDAI) to Release Quarterly Earnings on Wednesday](https://longbridge.com/en/news/280415885.md)
- [Spectral AI showcases DeepView system at British Burn Association annual conference](https://longbridge.com/en/news/290832000.md)
- [Spectral AI to report Q2 results, host conference call](https://longbridge.com/en/news/294256827.md)
- [Spectral AI rugi bersih Q2 FY26 menyempit 47,6% jadi USD 4,18 juta; revenue riset dan pengembangan turun 30,4% jadi USD 3,52 juta](https://longbridge.com/en/news/295573129.md)
- [Spectral Medical’s Tigris Trial Shows Survival Benefit in Endotoxic Septic Shock](https://longbridge.com/en/news/280311722.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**